From Studying Heart Disease and Cancer Simultaneously to Reverse Cardio-Oncology

Sanne De Wit; Rudolf A. De Boer

doi:10.1161/CIRCULATIONAHA.120.053315

From Studying Heart Disease and Cancer Simultaneously to Reverse Cardio-Oncology

Sanne De Wit, Rudolf A. De Boer^*

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

17 Citations (Scopus)

Original language	English
Pages (from-to)	93-95
Number of pages	3
Journal	Circulation
Volume	144
Issue number	2
DOIs	https://doi.org/10.1161/CIRCULATIONAHA.120.053315
Publication status	Published - 13 Jul 2021
Externally published	Yes

Bibliographical note

Funding Information:
The University Medical Center Groningen, which employs the authors, has received research grants from AstraZeneca, Abbott, Bristol-Myers Squibb, Novartis, Novo Nordisk, and Roche, outside the submitted work. Dr de Boer received speaker fees from Abbott, AstraZeneca, Novartis, and Roche, outside the submitted work.

Funding Information:
The authors are supported by the European Research Council (ERC CoG 818715, SECRETE-HF).

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1161/CIRCULATIONAHA.120.053315

Cite this

@article{7e94c06a0be9415e89a3fc5a143fa794,

title = "From Studying Heart Disease and Cancer Simultaneously to Reverse Cardio-Oncology",

author = "{De Wit}, Sanne and {De Boer}, {Rudolf A.}",

note = "Funding Information: The University Medical Center Groningen, which employs the authors, has received research grants from AstraZeneca, Abbott, Bristol-Myers Squibb, Novartis, Novo Nordisk, and Roche, outside the submitted work. Dr de Boer received speaker fees from Abbott, AstraZeneca, Novartis, and Roche, outside the submitted work. Funding Information: The authors are supported by the European Research Council (ERC CoG 818715, SECRETE-HF).",

year = "2021",

month = jul,

day = "13",

doi = "10.1161/CIRCULATIONAHA.120.053315",

language = "English",

volume = "144",

pages = "93--95",

journal = "Circulation",

issn = "0009-7322",

publisher = "Lippincott Williams & Wilkins",

number = "2",

}

TY - JOUR

T1 - From Studying Heart Disease and Cancer Simultaneously to Reverse Cardio-Oncology

AU - De Wit, Sanne

AU - De Boer, Rudolf A.

N1 - Funding Information: The University Medical Center Groningen, which employs the authors, has received research grants from AstraZeneca, Abbott, Bristol-Myers Squibb, Novartis, Novo Nordisk, and Roche, outside the submitted work. Dr de Boer received speaker fees from Abbott, AstraZeneca, Novartis, and Roche, outside the submitted work. Funding Information: The authors are supported by the European Research Council (ERC CoG 818715, SECRETE-HF).

PY - 2021/7/13

Y1 - 2021/7/13

UR - http://www.scopus.com/inward/record.url?scp=85110433588&partnerID=8YFLogxK

U2 - 10.1161/CIRCULATIONAHA.120.053315

DO - 10.1161/CIRCULATIONAHA.120.053315

M3 - Comment/Letter to the editor

C2 - 34251889

AN - SCOPUS:85110433588

SN - 0009-7322

VL - 144

SP - 93

EP - 95

JO - Circulation

JF - Circulation

IS - 2

ER -

From Studying Heart Disease and Cancer Simultaneously to Reverse Cardio-Oncology

Bibliographical note

UN SDGs

Access to Document

Other files and links

Cite this